A detailed history of International Biotechnology Trust PLC transactions in Karuna Therapeutics, Inc. stock. As of the latest transaction made, International Biotechnology Trust PLC holds 30,500 shares of KRTX stock, worth $0. This represents 1.75% of its overall portfolio holdings.

Number of Shares
30,500
Previous 25,700 18.68%
Holding current value
$0
Previous $5.57 Million 7.46%
% of portfolio
1.75%
Previous 1.74%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

BUY
$164.66 - $218.08 $790,368 - $1.05 Million
4,800 Added 18.68%
30,500 $5.16 Million
Q2 2023

Aug 08, 2023

BUY
$176.32 - $240.22 $2.59 Million - $3.53 Million
14,700 Added 133.64%
25,700 $5.57 Million
Q1 2023

May 18, 2023

BUY
$161.33 - $204.36 $1.77 Million - $2.25 Million
11,000 New
11,000 $2 Million
Q2 2022

Aug 16, 2022

BUY
$93.97 - $143.33 $147,250 - $224,598
1,567 New
1,567 $12.4 Million

Others Institutions Holding KRTX

About Karuna Therapeutics, Inc.


  • Ticker KRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 33,965,000
  • Description
  • Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...
More about KRTX
Track This Portfolio

Track International Biotechnology Trust PLC Portfolio

Follow International Biotechnology Trust PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of International Biotechnology Trust PLC, based on Form 13F filings with the SEC.

News

Stay updated on International Biotechnology Trust PLC with notifications on news.